158 related articles for article (PubMed ID: 15705475)
1. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants.
Esposito S; Pugni L; Bosis S; Proto A; Cesati L; Bianchi C; Cimino C; Mosca F; Principi N
Vaccine; 2005 Feb; 23(14):1703-8. PubMed ID: 15705475
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants.
Esposito S; Corbellini B; Bosis S; Pugni L; Tremolati E; Tagliabue C; Toneatto D; Mosca F; Principi N
Vaccine; 2007 Jun; 25(26):4889-94. PubMed ID: 17513025
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
[TBL] [Abstract][Full Text] [Related]
4. Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.
Wysocki J; Tansey S; Brachet E; Baker S; Gruber W; Giardina P; Arora A
Vaccine; 2010 Nov; 28(49):7779-86. PubMed ID: 20883736
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants.
Szynczewska E; Chlebna-Sokół D
Vaccine; 2011 Sep; 29(40):7107-13. PubMed ID: 21803093
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar ) in Korean infants: differences that are found in Asian children.
Kim NH; Lee J; Lee SJ; Lee H; Kim KH; Park SE; Lee HJ
Vaccine; 2007 Nov; 25(45):7858-65. PubMed ID: 17931753
[TBL] [Abstract][Full Text] [Related]
10. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
12. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
Shields B
J Pediatr Health Care; 2001; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
[No Abstract] [Full Text] [Related]
13. Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States.
Dennehy PH; Bertrand HR; Silas PE; Damaso S; Friedland LR; Abu-Elyazeed R
Pediatrics; 2008 Nov; 122(5):e1062-6. PubMed ID: 18977955
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
[TBL] [Abstract][Full Text] [Related]
15. Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Partridge S; Alvey J; Bernstein H; Blatter M; Bottenfield G; Guerrero J; Senders SD; Schuerman L; Cheuvart B; Holmes SJ
Vaccine; 2007 Feb; 25(10):1806-13. PubMed ID: 17240493
[TBL] [Abstract][Full Text] [Related]
16. [Immunogenicity and reactogenicity of DTPa-IPV-HBV/Hib and DTPa-IPV/Hib vaccines coadministered with 7-valent pneumococcal conjugate vaccine as primary vaccination and booster in healthy infants, according to the French vaccination calendar].
Reinert P; Dejos V; Clyti N; Abitbol V
Arch Pediatr; 2008 Mar; 15(3):263-70. PubMed ID: 18272353
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants.
Shinefield H; Black S; Ray P; Fireman B; Schwalbe J; Lewis E
Pediatr Infect Dis J; 2002 Mar; 21(3):182-6. PubMed ID: 12005078
[TBL] [Abstract][Full Text] [Related]
18. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E
Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
Trofa AF; Levin M; Marchant CD; Hedrick J; Blatter MM
Pediatr Infect Dis J; 2008 Jul; 27(7):658-60. PubMed ID: 18536623
[TBL] [Abstract][Full Text] [Related]
20. Immunization with the heptavalent pneumococcal conjugate vaccine in Bangladeshi infants and effects of zinc supplementation.
Osendarp SJ; Prabhakar H; Fuchs GJ; van Raaij JM; Mahmud H; Tofail F; Santosham M; Black RE
Vaccine; 2007 Apr; 25(17):3347-54. PubMed ID: 17289221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
